Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Warfarin Versus Rivaroxaban in Management of Post-myocardial Infarction Left Ventricular Thrombus in a Tertiary Cardiac Center of Nepal: a Randomized Control Study.

NCT05794399 is registered in ClinicalTrials.gov with Shahid Gangalal National Heart Centre as lead sponsor.

NCT NCT05794399
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05794399 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Warfarin Versus Rivaroxaban in Management of Post-myocardial Infarction Left Ventricular Thrombus in a Tertiary Cardiac Center of Nepal: a Randomized Control Study.
Lead sponsor
Shahid Gangalal National Heart Centre
Phase
Phase 4
Overall status
Recruiting
Start date
June 19, 2023
Completion date
April 30, 2026
Enrollment
196 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

left ventricular thrombus, myocardial infarction